Jacobs Levy Equity Management’s AtriCure ATRC Stock Holding History

Jacobs Levy Equity Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-30,259	Closed	-$621K	–	1021
2018 Q1	$621K	Buy	+30,259	New	+$546K	0.01%	741

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jacobs Levy Equity Management's ATRC Position: Q2 2018 in Review

Jacobs Levy Equity Management sold out of AtriCure (ATRC) in Q2 2018, closing a stake of 30,259 shares — an estimated $621K sold.

Jacobs Levy Equity Management first reported a position in ATRC in Q1 2018 and held it in 1 quarter. The position peaked at $621K in Q1 2018. 108 funds tracked by Wall St. Rank hold ATRC as of Q2 2018.

Jacobs Levy Equity Management reported no remaining AtriCure position as of Q2 2018 after selling out during the quarter.
Jacobs Levy Equity Management sold 30,259 AtriCure shares in Q2 2018, an estimated $621K.
Jacobs Levy Equity Management first reported a position in AtriCure in Q1 2018 and held it in 1 quarter.
Jacobs Levy Equity Management's AtriCure position peaked at $621K in Q1 2018.
108 funds tracked by Wall St. Rank held AtriCure as of Q2 2018.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.